Pharmacogenomics and the future of toxicology testing

Clinics in Laboratory Medicine

Volumn 32, Issue 3, 2012, Pages 509-523

  Agrawal, Yash Pal ^a   Rennert, Hanna ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Autopsy; Drugs; Pharmacogenetics; Pharmacogenomics; Toxicology

Indexed keywords

CARISOPRODOL; CITALOPRAM; CODEINE; CYTOCHROME P450 2D6; DIAMORPHINE; HYDROCODONE; MORPHINE; OXYCODONE; RISPERIDONE; TRAMADOL;

ADRB2 GENE; ALCOHOL CONSUMPTION; AUTOPSY; CYP2D6 GENE; DRUG ABUSE; DRUG MISUSE; DRUG MONITORING; DRUG TARGETING; ENZYME ASSAY; GENE FREQUENCY; GENETIC DATABASE; GENETIC POLYMORPHISM; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; MUTATOR GENE; PATIENT CARE; PATIENT IDENTIFICATION; PHARMACOGENETICS; PHARMACOGENOMICS; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; TOXICITY TESTING; VKORC1 GENE;

AUTOPSY; DATABASES, GENETIC; DRUG LABELING; HUMANS; PHARMACEUTICAL PREPARATIONS; PHARMACOGENETICS; TOXICITY TESTS;

EID: 84865597900     PISSN: 02722712     EISSN: 15579832     Source Type: Journal    
DOI: 10.1016/j.cll.2012.07.009     Document Type: Review

References (42)

1. Weinshilboum R.M., Wang L. Pharmacogenetics and pharmacogenomics: development, science, and translation. Annu Rev Genomics Hum Genet 2006, 7:223-245.
2. Linder M.W., Valdes R. Pharmacogenetics in the practice of laboratory medicine. Mol Diagn 1999, 4:365-379.
3. Swen J.J., Nijenhuis M., de Boer A., et al. Pharmacogenetics: from bench to byte-an update of guidelines. Clin Pharmacol Ther 2011, 89:662-673.
4. Becquemont L., Alfirevic A., Amstutz U., et al. Practical recommendations for pharmacogenomics-based prescription: 2010 ESF-UB Conference on Pharmacogenetics and Pharmacogenomics. Pharmacogenomics 2011, 12:113-124.
5. Amstutz U., Carleton B.C. Pharmacogenetic testing: time for clinical practice guidelines. Clin Pharmacol Ther 2011, 89:924-927.
6. Scott S.A. Personalizing medicine with clinical pharmacogenetics. Genet Med 2011, 13:987-995.
7. Johnson J.A., Gong L., Whirl-Carrillo M., et al. Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing. Clin Pharmacol Ther 2011, 90:625-629.
8. Chan A., Pirmohamed M., Comabella M. Pharmacogenomics in neurology: current state and future steps. Ann Neurol 2011, 70:684-697.
9. Roden D.M., Johnson J.A., Kimmel S.E., et al. Cardiovascular pharmacogenomics. Circ Res 2011, 109:807-820.
10. Ma Q., Lu A.Y. Pharmacogenetics, pharmacogenomics, and individualized medicine. Pharmacol Rev 2011, 63:437-459.
11. Table of pharmacogenomic biomarkers in drug labels U.S. Food and Drug Administration, Accessed April 9, 2012. http://www.fda.gov/drugs/scienceresearch/researchareas/pharmacogenetics/ucm083378.htm.
12. Johansson I., Ingelman-Sundberg M. Genetic polymorphism and toxicology-with emphasis on cytochrome p450. Toxicol Sci 2011, 120:1-13.
13. Amstutz U., Carleton B.C. Pharmacogenetic testing: time for clinical practice guidelines. Clin Pharmacol Ther 2011, 89:924-927.
14. The Human Cytochrome P450 (CYP) Allele Nomenclature Database Ingelman-Sundberg M, Daly AK, Nebert DW, et al, editors, Accessed August 8, 2012. http://www.cypalleles.ki.se.
15. National Estimates of Drug-Related Emergency Department Visits. HHS Publication No. (SMA) 11-4659, DAWN Series D-35 2011, Substance Abuse and Mental Health Services Administration, Drug Abuse Warning Network, 2009, Substance Abuse and Mental Health Services Administration, Rockville (MD), Accessed August 8, 2012. http://www.samhsa.gov/data/2k11/DAWN/2k9DAWNED/HTML/DAWN2k9ED.htm.
16. Bissell M.G., Peat M.A. Clinical toxicology testing: a guide for laboratory professionals 2012, 140-147. CAP Press, Northfield (IL). B.J. Magnani, M.G. Bissell, T.C. Kwong (Eds.).
17. Smith H.S. Opioid metabolism. Mayo Clin Proc 2009, 84:613-624.
18. Crews K.R., Gaedigk A., Dunnenberger H.M., et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotype. Clin Pharmacol Ther 2012, 91:321-326. Clinical Pharmacogenetics Implementation Consortium.
19. Meyer M.R., Maurer H.H. Absorption, distribution, metabolism and excretion pharmacogenomics of drugs of abuse. Pharmacogenomics 2011, 12:215-233.
20. Maurer H.H., Sauer C., Theobald D.S. Toxicokinetics of drugs of abuse: current knowledge of the isoenzymes involved in the human metabolism of tetrahydrocannabinol, cocaine, heroin, morphine, and codeine. Ther Drug Monit 2006, 28:447-453.
21. Levo A., Koski A., Ojanperä I., et al. Post-mortem SNP analysis of CYP2D6 gene reveals correlation between genotype and opioid drug (tramadol) metabolite ratios in blood. Forensic Sci Int 2003, 135:9-15.
22. Jannetto P.J., Bratanow N.C. Pain management in the 21st century: utilization of pharmacogenomics and therapeutic drug monitoring. Expert Opin Drug Metab Toxicol 2011, 7:745-752.
23. Lippi G., Plebani M. Pharmacogenomics of alcohol metabolism: implications for legal testing. Clin Chem Lab Med 2011, 49:9-11.
24. Skopp G. Preanalytic aspects in postmortem toxicology. Forensic Sci Int 2004, 142:75-100.
25. Skopp G. Postmortem toxicology. Forensic Sci Med Pathol 2010, 6:314-325.
26. Drummer O.H. Postmortem toxicology of drugs of abuse. Forensic Sci Int 2004, 142:101-113.
27. Sajantila A., Palo J.U., Ojanperä I., et al. Pharmacogenetics in medico-legal context. Forensic Sci Int 2010, 203:44-52.
28. Frost J., Helland A., Nordrum I.S., et al. Investigation of morphine and morphine glucuronide levels and cytochrome P450 isoenzyme 2D6 genotype in codeine-related deaths. Forensic Sci Int 2012, 220(1-3):6-11.
29. Wong S.H., Wagner M.A., Jentzen J.M., et al. Pharmacogenomics as an aspect of molecular autopsy for forensic pathology/toxicology: does genotyping CYP 2D6 serve as an adjunct for certifying methadone toxicity?. J Forensic Sci 2003, 48:1406-1415.
30. Jannetto P.J., Wong S.H., Gock S.B., et al. Pharmacogenomics as molecular autopsy for postmortem forensic toxicology: genotyping cytochrome P450 2D6 for oxycodone cases. J Anal Toxicol 2002, 26:438-447.
31. Levo A., Koski A., Ojanperä I., et al. Post-mortem SNP analysis of CYP2D6 gene reveals correlation between genotype and opioid drug (tramadol) metabolite ratios in blood. Forensic Sci Int 2003, 135:9-15.
32. Jin M., Gock S.B., Jannetto P.J., et al. Pharmacogenomics as molecular autopsy for forensic toxicology: genotyping cytochrome P450 3A4*1B and 3A5*3 for 25 fentanyl cases. J Anal Toxicol 2005, 29:590-598.
33. Madadi P., Ross C.J., Hayden M.R., et al. Pharmacogenetics of neonatal opioid toxicity following maternal use of codeine during breastfeeding: a case-control study. Clin Pharmacol Ther 2009, 85:31-35.
34. Neuvonen A.M., Palo J.U., Sajantila A. Post-mortem ABCB1 genotyping reveals an elevated toxicity for female digoxin users. Int J Legal Med 2011, 125:265-269.
35. Koski A., Sistonen J., Ojanperä I., et al. CYP2D6 and CYP2C19 genotypes and amitriptyline metabolite ratios in a series of medicolegal autopsies. Forensic Sci Int 2006, 158:177-183.
36. Johansson I., Lundqvist E., Bertilsson L., et al. Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine. Proc Natl Acad Sci U S A 1993, 90:11825-11829.
37. Aklillu E., Persson I., Bertilsson L., et al. Frequent distribution of ultrarapid metabolizers of debrisoquine in an Ethiopian population carrying duplicated and multiduplicated functional CYP2D6 alleles. J Pharmacol Exp Ther 1996, 278:441-446.
38. Dahl M.L., Johansson I., Bertilsson L., et al. Ultrarapid hydroxylation of debrisoquine in a Swedish population: analysis of the molecular genetic basis. J Pharmacol Exp Ther 1995, 274:516-520.
39. Mahgoub A., Idle J.R., Dring L.G., et al. Polymorphic hydroxylation of debrisoquine in man. Lancet 1977, 2:584-586.
40. Allele Frequency database Accessed August 8, 2012. http://alfred.med.yale.edu/.
41. van Baal S., Kaimakis P., Phommarinh M., et al. FINDbase: a relational database recording frequencies of genetic defects leading to inherited disorders worldwide. Nucleic Acids Res 2007, 35:D690-D695. [Database issue].
42. Pharmacogenomics Knowledge Base Accessed August 8, 2012. http://www.pharmgkb.org.